Zevia PBC reports results for the quarter ended June 30 - Earnings Summary
Zevia PBC reports results for the quarter ended June 30 - Earnings Summary
Zevia PBC ZVIA.N reported a quarterly adjusted loss of 4 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of six analysts for the quarter was for a loss of 3 cents per share. Wall Street expected results to range from -4 cents to -2 cents per share.
Revenue rose 1.1% to $45.00 million from a year ago; analysts expected $44.21 million.
Zevia PBC's reported EPS for the quarter was a loss of 4 cents.
The company reported a quarterly loss of $2.81 million.
Zevia PBC shares had risen by 6.1% this quarter and lost 25.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 80% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the non-alcoholic beverages peer group is also "buy"
Wall Street's median 12-month price target for Zevia PBC is $3.50, about 50.6% above its last closing price of $1.73
This summary was machine generated from LSEG data August 5 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.03 | -0.04 | Missed |
Mar. 31 2026 | -0.03 | -0.03 | Met |
Dec. 31 2025 | -0.03 | -0.02 | Beat |
Sep. 30 2025 | -0.06 | -0.04 | Beat |
Recent news on Zevia PBC
See all newsZevia PBC reports results for the quarter ended September 30 - Earnings Summary
Corrected: Zevia Q3 sales rise on volume growth, pricing actions
Brief: Zevia Q3 Sales USD 48.343 Million Vs. IBES Estimate USD 44.7 Million
Brief: Zevia Announces $20 Million Growth Equity Investment
Brief: Zevia Statement Regarding Kanen Wealth Management